Estimating the influence of rescreening interval on the benefits associated with cancer screening: Approaches and limitations

Noel S. Weiss, Ruth Etzioni

Research output: Contribution to journalReview article

16 Scopus citations

Abstract

Randomized controlled trials that seek to measure the ability of a screening test to lower cancer mortality generally do not provide data that bear on the relative efficacy of different screening intervals. Guidance regarding the choice of a screening interval that achieves a high level of case-finding, without being excessively costly, can be obtained from one or more of several study designs that examine the subsequent occurrence of cancer in persons who have had a negative screening test. However, each of these can potentially provide a misleading result, and so their limitations must be considered before using the data they generate to develop a rational rescreening policy.

Original languageEnglish (US)
Pages (from-to)713-717
Number of pages5
JournalEpidemiology
Volume13
Issue number6
DOIs
StatePublished - Nov 1 2002

ASJC Scopus subject areas

  • Epidemiology

Fingerprint Dive into the research topics of 'Estimating the influence of rescreening interval on the benefits associated with cancer screening: Approaches and limitations'. Together they form a unique fingerprint.

  • Cite this